England’s National Health Service has lifted restrictions on Janssen’s blood cancer drug Imbruvica (ibrutinib), after a journalist who was suffering from chronic lymphocytic leukaemia (CLL) was denied access. The UK’s Press Gazette reported that T...
Original Article: NHS lifted Imbruvica restrictions after press campaign